3,647 result(s) found
Markets Stroll Higher Ahead of Key Data; SMCI, FFIV, WHR Beat
https://www.zacks.com/stock/news/2217484/markets-stroll-higher-ahead-of-key-data-smci-ffiv-whr-beat?cid=CS-ZC-FT-ahead_of_wall_street-2217484
Jan 29, 2024 - A sixth record closing high for the S&P 500 just this month/year alone ought to give a good impression of where the market's collective head is at presently.
0
Twin Cities home sales down 18% last year, the lowest in 20 years
https://www.startribune.com/twin-cities-home-sales-lowest-20-years/600339465/
Jan 29, 2024 - New-build home sales were up but did not make up for the low inventory of previously sold homes.
0
Evolus, Alvotech gain as Barclays raises to Ovrweight
https://seekingalpha.com/news/4059650-evolus-stock-alvotech-stock-gain-barclays-upgrades?source=feed_sector_healthcare
Jan 29, 2024 - Barclays upgrades Evolus (EOLS) and Alvotech (ALVO), leading to a run-up in their share prices. Find out reasons behind the upgrade.
0
Eagle Materials (EXP) Is Up 5.61% in One Week: What You Should Know
https://www.zacks.com/stock/news/2217360/eagle-materials-exp-is-up-5-61-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2217360
Jan 29, 2024 - Does Eagle Materials (EXP) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
GSK Gears Up for Q4 Earnings: Will It Surpass Estimates?
https://www.zacks.com/stock/news/2217328/gsk-gears-up-for-q4-earnings-will-it-surpass-estimates?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217328
Jan 29, 2024 - We expect GSK's specialty products like Arexvy, Cabenuva, Dovato, Bexsero, Trelegy Ellipta and Shingrix to drive fourth-quarter sales performance.
0
Skechers (SKX) Gears Up for Q4 Earnings: What Lies Ahead?
https://www.zacks.com/stock/news/2217275/skechers-skx-gears-up-for-q4-earnings-what-lies-ahead?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217275
Jan 29, 2024 - Skechers' (SKX) Q4 results are expected to reflect robust growth, driven by DTC and international sales, along with effective operating cost management, indicating positive revenue and earnings prospects.
0
TEGNA's (TGNA) Sports Portfolio Gets a Boost With New Deal
https://www.zacks.com/stock/news/2217271/tegna-s-tgna-sports-portfolio-gets-a-boost-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2217271
Jan 29, 2024 - TEGNA (TGNA) ramps up its sports content portfolio with the deal between WFAA and NBA's team to air 10 additional games.
0
BD (BDX) Gears Up for Q1 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2217270/bd-bdx-gears-up-for-q1-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217270
Jan 29, 2024 - Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited fiscal first-quarter sales.
0
SoFi Earnings: Why Are Shares Soaring After Earnings?
https://www.fool.com/investing/2024/01/29/sofi-earnings-why-are-shares-soaring-after-earning/?source=iedfolrf0000001
Jan 29, 2024 - SoFi stock is up since the company reported Q4 earnings. Is the stock a buy right now?
0
The George Carlin ‘AI’ Stand-Up Creators Now Say a Human Wrote the Jokes
https://www.wired.com/story/george-carlin-ai-standup-written-by-humans/
Jan 29, 2024 - A lawsuit filed by George Carlin’s manager will still move forward.
0